These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 39190265)
1. SRF Facilitates Transcriptional Inhibition of Gem Expression by m6A Methyltransferase METTL3 to Suppress Neuronal Damage in Epilepsy. Li L; Liu Z Mol Neurobiol; 2024 Aug; ():. PubMed ID: 39190265 [TBL] [Abstract][Full Text] [Related]
2. Metformin attenuates multiple myeloma cell proliferation and encourages apoptosis by suppressing METTL3-mediated m6A methylation of THRAP3, RBM25, and USP4. Chen CJ; Huang JY; Huang JQ; Deng JY; Shangguan XH; Chen AZ; Chen LT; Wu WH Cell Cycle; 2023 Apr; 22(8):986-1004. PubMed ID: 36762777 [TBL] [Abstract][Full Text] [Related]
3. The m6A methyltransferase METTL3 drives thyroid cancer progression and lymph node metastasis by targeting LINC00894. Zhou X; Chang L; Liang Q; Zhao R; Xiao Y; Xu Z; Yu L Cancer Cell Int; 2024 Jan; 24(1):47. PubMed ID: 38291427 [TBL] [Abstract][Full Text] [Related]
4. m6A-related bioinformatics analysis and functional characterization reveals that METTL3-mediated NPC1L1 mRNA hypermethylation facilitates progression of atherosclerosis via inactivation of the MAPK pathway. Zhang G; Li X; Huang X Inflamm Res; 2023 Mar; 72(3):429-442. PubMed ID: 36583755 [TBL] [Abstract][Full Text] [Related]
5. Study on the Mechanism of Xianling Gubao Capsule Regulating Runt-Related Transcription Factor 2 (RUNX2) and Promoting Osteoblast Differentiation by N6-Methyladenosine (m6A) Methyltransferase-Like 3 (METTL3). Liao M; He Q; Yang J; Gou L; Ma K; Wang H Altern Ther Health Med; 2024 Jun; ():. PubMed ID: 38940781 [TBL] [Abstract][Full Text] [Related]
6. Integrative proteomics and m6A microarray analyses of the signatures induced by METTL3 reveals prognostically significant in gastric cancer by affecting cellular metabolism. Peng G; Chen S; Zheng N; Tang Y; Su X; Wang J; Dong R; Wu D; Hu M; Zhao Y; Liu M; Wu H Front Oncol; 2022; 12():996329. PubMed ID: 36465351 [TBL] [Abstract][Full Text] [Related]
7. Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt/β-catenin signalling pathway. Cui X; Wang Z; Li J; Zhu J; Ren Z; Zhang D; Zhao W; Fan Y; Zhang D; Sun R Cell Prolif; 2020 Mar; 53(3):e12768. PubMed ID: 31967701 [TBL] [Abstract][Full Text] [Related]
8. Human aortic smooth muscle cell regulation by METTL3 via upregulation of m6A NOTCH1 modification and inhibition of NOTCH1. Yang J; Fang M; Yu C; Li Z; Wang Q; Li C; Wu J; Fan R Ann Transl Med; 2023 Aug; 11(10):350. PubMed ID: 37675298 [TBL] [Abstract][Full Text] [Related]
9. Transcription factor RELA promotes hepatocellular carcinoma progression by promoting the transcription of m6A modulator METTL3. Wu J; Wang W; Zheng Y; Deng W; Liu J Pathol Res Pract; 2024 Mar; 255():155168. PubMed ID: 38367599 [TBL] [Abstract][Full Text] [Related]
10. METTL3 exerts synergistic effects on m6A methylation and histone modification to regulate the function of VGF in lung adenocarcinoma. Shi K; Sa R; Dou L; Wu Y; Dong Z; Fu X; Yu H Clin Epigenetics; 2023 Sep; 15(1):153. PubMed ID: 37742030 [TBL] [Abstract][Full Text] [Related]
11. METTL3/IGF2BP2 axis affects the progression of colorectal cancer by regulating m6A modification of STAG3. Yi J; Peng F; Zhao J; Gong X Sci Rep; 2023 Oct; 13(1):17292. PubMed ID: 37828232 [TBL] [Abstract][Full Text] [Related]
12. Genetic and pharmacological inhibition of METTL3 alleviates renal fibrosis by reducing EVL m6A modification through an IGF2BP2-dependent mechanism. Ni WJ; Zhou H; Lu H; Ma NN; Hou BB; Li W; Kong FX; Yu JT; Hou R; Jin J; Wen JG; Zhang T; Meng XM Clin Transl Med; 2023 Aug; 13(8):e1359. PubMed ID: 37537731 [TBL] [Abstract][Full Text] [Related]
13. Chinese Ecliptae herba (Eclipta prostrata (L.) L.) extract and its component wedelolactone enhances osteoblastogenesis of bone marrow mesenchymal stem cells via targeting METTL3-mediated m6A RNA methylation. Tian S; Li YL; Wang J; Dong RC; Wei J; Ma Y; Liu YQ J Ethnopharmacol; 2023 Aug; 312():116433. PubMed ID: 37004744 [TBL] [Abstract][Full Text] [Related]
14. Methyltransferase METTL3 governs the modulation of SH3BGR expression through m6A methylation modification, imparting influence on apoptosis in the context of Down syndrome-associated cardiac development. Shi W; Chen R; Zhou M; Li Y; Zhang Y; Wang J; Hao B; Liao S Cell Death Discov; 2024 Sep; 10(1):396. PubMed ID: 39237501 [TBL] [Abstract][Full Text] [Related]
15. METTL3-Mediated N6-Methyladenosine Modification of lncRNA D26496 Suppresses the Proliferation and Migration of Schwann Cells after Sciatic Nerve Injury. He X; Zhang J; Guo Y; Yang X; Huang Y; Hao D Mol Neurobiol; 2023 May; 60(5):2413-2425. PubMed ID: 36656457 [TBL] [Abstract][Full Text] [Related]
16. METTL3 promotes osteogenic differentiation of human umbilical cord mesenchymal stem cells by up-regulating m6A modification of circCTTN. Chen S; Duan X; He Y; Chen W Biosci Rep; 2024 Mar; 44(3):. PubMed ID: 38358895 [TBL] [Abstract][Full Text] [Related]
17. N(6)-methyladenosine RNA methyltransferase like 3 inhibits extracellular matrix synthesis of endplate chondrocytes by downregulating sex-determining region Y-Box transcription factor 9 expression under tension. Xiao L; Hu B; Ding B; Zhao Q; Liu C; Öner FC; Xu H Osteoarthritis Cartilage; 2022 Apr; 30(4):613-625. PubMed ID: 35007741 [TBL] [Abstract][Full Text] [Related]